Aldesleukin Completed Phase 1 / 2 Trials for Type 1 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00525889Proleukin and Rapamune in Type 1 Diabetes